What ARMO BioSciences, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Gordon Carl L | Director | Jun 22 | Tender Offer · U | −409,547 | $50.00 | −$20.5M | 0 |
| Gordon Carl L | Director | Jun 22 | Tender Offer · U | −3,709,356 | $50.00 | −$185M | 0 |
| Cui Xiangmin | Director | Jun 22 | Tender Offer · U | −1,214,700 | $50.00 | −$60.7M | 0 |
| Seidenberg Beth C | Director | Jun 22 | Tender Offer · U | −4,266,683 | $50.00 | −$213M | 0 |
| Orbimed Advisors Llc | Director | Jun 22 | Tender Offer · U | −409,547 | $50.00 | −$20.5M | 409,547 |
| Orbimed Advisors Llc | Director | Jun 22 | Tender Offer · U | −3,709,356 | $50.00 | −$185M | 3,709,356 |
| Kleiner Perkins Caufield & Byers XIV, Llc | 10% owner | Jun 22 | Tender Offer · U | −4,266,683 | $50.00 | −$213M | 0 |
| Van Vlasselaer Peter | President and CEO | Jun 22 | Tender Offer · U | −809,865 | $50.00 | −$40.5M | 0 |
| Xu Stella | Director | Jun 22 | Tender Offer · U | −404,900 | $50.00 | −$20.2M | 0 |
| Gv 2016 GP, L.l.c. | 10% owner | Jan 30 | Derivative Conversion · C | +607,350 | — | — | 607,350 |
| Gv 2014 GP, L.l.c. | 10% owner | Jan 30 | Derivative Conversion · C | +607,350 | — | — | 607,350 |
| Hsg Venture Vi Management, L.p. | 10% owner | Jan 30 | Derivative Conversion · C | +809,800 | — | — | 809,800 |
| Gordon Carl L | Director | Jan 30 | Derivative Conversion · C | +409,547 | — | — | 409,547 |
| Gordon Carl L | Director | Jan 30 | Derivative Conversion · C | +3,709,356 | — | — | 3,709,356 |
| Cui Xiangmin | Director | Jan 30 | Derivative Conversion · C | +1,214,700 | — | — | 1,214,700 |
| Seidenberg Beth C | Director | Jan 30 | Derivative Conversion · C | +4,266,683 | — | — | 4,266,683 |
| Orbimed Advisors Llc | Director | Jan 30 | Derivative Conversion · C | +409,547 | — | — | 409,547 |
| Orbimed Advisors Llc | Director | Jan 30 | Derivative Conversion · C | +3,709,356 | — | — | 3,709,356 |
| Kleiner Perkins Caufield & Byers XIV, Llc | 10% owner | Jan 30 | Derivative Conversion · C | +4,266,683 | — | — | 4,266,683 |
| Xu Stella | Director | Jan 30 | Derivative Conversion · C | +404,900 | — | — | 404,900 |
Loading...
